The pharma brand 'that matters'

Posted 13 December 2024 PM

Eli Lilly has been named one of Fast Company's Brands That Matter, the only pharma this year to make the cut of brands that have made themselves an integral part of their customers' lives while also carving out a space in the broader culture.

Lilly was elevated to the list thanks to its effort to discourage cosmetic use of its dual GLP-1/GIP receptor agonist Mounjaro, which limits access for those who actually need the drugs to treat diabetes or obesity.

To see the whole article, please login